InvestingintheFutureofTennis.
MADDAN Corp. is raising $5M at a $12M–$15M pre-money valuation to build the world's first self-healing tennis ball — and the ecosystem around it. Three provisional patents filed. Dual-track GTM proven. The category window is open now.
The Opportunity
330 Million Balls. 150 Years. Zero Solutions — Until Now.
The global tennis ball market stands at $1.7B in 2026 and is projected to reach $3.0B by 2035 at 6.5% CAGR. The premium durability and sustainability segment — our blue ocean — has no dominant player. Wilson Triniti is the primary competitor, and it still degrades after 18–25 games. MaddBall is engineered to last 54+ games on felt alone, with a self-healing core that retains 99.8% pressure after 500+ games.
Self-healing polymers are growing at 23% CAGR — from $3.45B today to $27B+ by 2035. Zero competitors have applied this technology to tennis balls. We are the first mover and will own the new category. The incumbent dilemma is our permanent advantage: Wilson, Head, and Penn make $1.7B/year on replacement sales. True durability would destroy that revenue stream. They cannot innovate without destroying themselves.
Market Opportunity
$27B+ by 2035
The Investment Thesis
One Category. Zero Competition.
The incumbent dilemma is our permanent advantage. Wilson, Head, and Penn cannot innovate without destroying themselves.
Competitive Positioning
MADDAN vs. The Incumbents
Patent Moat
3 interlocking provisional patents filed April 2026. Each cross-references the others — protecting a category, not just a product. 17+ years of utility patent protection.
Technology Barrier
Reversible Diels-Alder chemistry + nano-felt electrospray deposition. 5–7 year first-mover head start before competitors can reverse-engineer and design around it.
Incumbent Dilemma
Wilson, Head, and Penn make $1.7B/year on replacement sales. True durability destroys that model. They cannot compete without cannibalizing themselves.
Market Timing
Self-healing polymers growing at 23% CAGR. Zero competitors have applied this technology to tennis. The category window is open now — and closing.
Select Your Investment
Three Brands. Three Opportunities.
Each Maddan sub-brand operates as a distinct investment vehicle with its own market, technology moat, and commercialization timeline.
Investment Profile
MaddBall
The World's First Self-Healing Tennis Ball.
$1.7B
Market size
Prototype & Validation
Current stage
Current Traction
3 provisional patents filed April 2026. Independent lab testing protocol in place. Survey of 200 players: 87% want a dramatically longer-lasting ball, 73% willing to pay $15–18/can premium. 15 club manager interviews: 100% cite ball cost as a top-three operational challenge.
Revenue Pipeline
Q4 2026 recreational Amazon launch target — MaddBall Training and Junior (no ITF approval needed). Year 1 revenue target: $1.0M–$1.5M. ITF approval targeted Q2 2027, activating the pro track. Year 5 (2031): $65M–$85M revenue, $300M–$450M valuation.
Technology
Elastomeric core uses reversible Diels-Alder chemistry — furan and maleimide groups recombine at crack sites on impact, sealing micro-cracks within seconds. Nano-felt cover reinforced with silica nanoparticles and graphene oxide delivers 3× durability and 98% less microplastic shedding. 99.8% pressure retention after 500+ games vs. 60–80% for conventional balls.
Competitive Moat
Three interlocking provisional patents filed April 2026 — each cross-references the others. Together they protect a category, not just a product. 17+ years of utility patent protection. 5–7 year first-mover head start before competitors can reverse-engineer and design around it. Trade secret protection on exact furan/maleimide ratios, thermal activation parameters, and deposition processes.
Milestone Roadmap
3 provisional patents filed (April 2026)
Independent lab testing initiated
Seed round closes ($5M)
Q4 2026 Amazon recreational launch
Q2 2027 ITF approval — pro track activated
Use of Investment Funds
Portfolio at a Glance
One Platform. Three Revenue Streams.
Prototype & Validation
MaddBall
$1.7B
The World's First Self-Healing Tennis Ball.
Development
MaddStrings
Platform
The MADD Platform Extended to Strings and Frames.
Brand Development
MaddLife
Ecosystem
Sustainable Apparel and Accessories. The MADD Ecosystem Complete.
Leadership
Built by Scientists.
Scaled by Operators.
The Maddan founding team combines deep materials science expertise with commercial execution experience across global sports markets. This is not a first-time team.
Chris Maddan
Founder & CEO
Vision, strategy, fundraising, and partnerships. Identified a 150-year design flaw in tennis equipment, engineered a molecular fix, filed three interlocking patents, and built a dual-track GTM — before raising a dollar. Full-time post-seed.
Jennifer Maddan
President
Leads strategic direction, operations, and organisational growth. Oversees day-to-day execution, investor relations support, and the cross-functional teams driving MADDAN Corp. from prototype to commercial scale.
Risk Disclosure
We Believe in Transparency.
Every investment carries risk. We present ours plainly so that prospective investors can make informed decisions.
Technology Development Risk
MaddBall's self-healing technology remains in development and testing. All performance, durability, and sustainability claims reflect targeted outcomes based on prototype testing and preliminary data as of April 2026. Actual results may differ materially. Independent lab certification and ITF approval are key milestones that must be achieved before commercial launch.
ITF Approval Timeline
ITF approval is targeted for Q2 2027 via independent lab validation. If delayed 6 months, Year 1 revenue drops approximately 40% to $600K–$900K — still breakeven with seed funding, as the recreational track (pressureless and training balls) does not require ITF approval. If delayed 12 months, Year 1 revenue drops 60%, but the business remains cash-positive by Year 2 in all scenarios.
Manufacturing Scale Risk
Scaling Diels-Alder chemistry and nano-felt electrospray deposition to commercial volumes requires capital and operational execution. Phase 1 targets 5K–10K prototype units with NDA contract manufacturing partners. Phase 2 scales to 1M+ units/year with Asian contract manufacturers. Phase 3 moves to a dedicated facility by 2029. Each phase is funded by the prior phase's cash flow.
Competitive Response
Wilson, Head, and Penn control 80%+ of the global market but face a structural cannibalization dilemma — true durability would destroy their replacement-sale revenue model. Low threat through 2028. Medium threat from 2029 as MaddBall reaches $12M–$18M revenue, at which point acquisition becomes more likely than direct competition. The three-patent IP thicket provides 17+ years of protection and a 5–7 year first-mover head start.
Next Steps
$5M to Own a Category.
MADDAN Corp. is raising $5M at a $12M–$15M pre-money valuation ($17M–$20M post-money). 18+ months runway to first revenue and ITF approval. Every dollar is tied to a milestone. If you represent capital aligned with deep-technology sports innovation and sustainability, we want to hear from you.